Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T D'Aquila

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Microbiology|November 4, 2000
Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture methodC L Tremblay, F Giguel, D P Merrill, et al.
The Journal of Infectious Diseases|October 1, 1991
Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitroV A Johnson, D P Merrill, J A Videler, et al.
The Journal of Experimental Medicine|April 1, 1994
Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoireS A Kalams, R P Johnson, A K Trocha, et al.
The Journal of Infectious Diseases|March 18, 2000
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapineG J Hanna, V A Johnson, D R Kuritzkes, et al.
AIDS (London, England)|March 14, 2000
Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapyH M Precious, H F Günthard, J K Wong, et al.
JAMA|July 13, 2001
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapyM Hermankova, S C Ray, C Ruff, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 InvestigatorsX J Zhou, L B Sheiner, R T D'Aquila, et al.
The Journal of Infectious Diseases|January 7, 1999
Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapyD P Merrill, J Martinez-Picado, C Tremblay, et al.
AIDS Research and Human Retroviruses|June 1, 1993
Interactions between HIV-1 and cytomegalovirus in human osteosarcoma cells carrying both virusesM Margalith, D J Medina, G D Hsiung, et al.
The Journal of Infectious Diseases|July 1, 1995
Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agentsC C Wilson, J T Wong, D D Girard, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Microbiology|November 4, 2000
Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture methodC L Tremblay, F Giguel, D P Merrill, et al.
The Journal of Infectious Diseases|October 1, 1991
Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitroV A Johnson, D P Merrill, J A Videler, et al.
The Journal of Experimental Medicine|April 1, 1994
Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoireS A Kalams, R P Johnson, A K Trocha, et al.
The Journal of Infectious Diseases|March 18, 2000
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapineG J Hanna, V A Johnson, D R Kuritzkes, et al.
AIDS (London, England)|March 14, 2000
Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapyH M Precious, H F Günthard, J K Wong, et al.
JAMA|July 13, 2001
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapyM Hermankova, S C Ray, C Ruff, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 InvestigatorsX J Zhou, L B Sheiner, R T D'Aquila, et al.
The Journal of Infectious Diseases|January 7, 1999
Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapyD P Merrill, J Martinez-Picado, C Tremblay, et al.
AIDS Research and Human Retroviruses|June 1, 1993
Interactions between HIV-1 and cytomegalovirus in human osteosarcoma cells carrying both virusesM Margalith, D J Medina, G D Hsiung, et al.
The Journal of Infectious Diseases|July 1, 1995
Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agentsC C Wilson, J T Wong, D D Girard, et al.
Pageof 7